In a paper published in Frontiers of Engineering Management, researchers conducted a meta-analysis of 62 empirical studies ...
Below is Validea's guru fundamental report for META PLATFORMS INC (META). Of the 22 guru strategies we follow, META rates highest using our Twin Momentum Investor model based on the published strategy ...
Medpage Today on MSN
Meta-Analyses Argue for Broader Use of SGLT2 Inhibitors in Chronic Kidney Disease
The first meta-analysis analyzed 70,361 participants from 10 randomized trials, and found those allocated to receive an SGLT2 ...
Meta Platforms (NASDAQ:META) is set to publish its earnings report on Wednesday, April 30, 2025. Historically, the stock’s response to earnings has been fairly balanced, with a 50% probability of a ...
Trastuzumab emtansine is linked to a lower incidence of decrease in left ventricular ejection fraction than other trastuzumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback